About Delve Bio
Delve Bio is a company based in San Francisco (United States) founded in 2022 by Bradley Murray.. Delve Bio has raised $35 million across 1 funding round from investors including Xontogeny, Google Ventures and S32. Delve Bio offers products and services including Delve Detect. Delve Bio operates in a competitive market with competitors including Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others.
- Headquarter San Francisco, United States
- Founders Bradley Murray
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Delve Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$35 M (USD)
in 1 rounds
-
Latest Funding Round
$35 M (USD), Series A
Jun 20, 2023
-
Investors
Xontogeny
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Delve Bio
Delve Bio offers a comprehensive portfolio of products and services, including Delve Detect. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Metagenomic sequencing for comprehensive pathogen identification in infections
Unlock access to complete
Funding Insights of Delve Bio
Delve Bio has successfully raised a total of $35M through 1 strategic funding round. The most recent funding activity was a Series A round of $35 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $35.0M
-
First Round
First Round
(20 Jun 2023)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Series A - Delve Bio | Valuation | Xontogeny |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Delve Bio
Delve Bio has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Xontogeny, Google Ventures and S32. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Life science startups are accelerated through focused programs by Xontogeny.
|
Founded Year | Domain | Location | |
|
Tech startups are funded by S32, a venture capital entity.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Delve Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Delve Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Delve Bio Comparisons
Competitors of Delve Bio
Delve Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Delve Bio
Frequently Asked Questions about Delve Bio
When was Delve Bio founded?
Delve Bio was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Where is Delve Bio located?
Delve Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Delve Bio?
Bradley Murray is the current CEO of Delve Bio. They have also founded this company.
Is Delve Bio a funded company?
Delve Bio is a funded company, having raised a total of $35M across 1 funding round to date. The company's 1st funding round was a Series A of $35M, raised on Jun 20, 2023.
What does Delve Bio do?
Delve Bio was founded in 2022 and is headquartered in San Francisco, United States. A metagenomic next-generation sequencing (mNGS) platform is provided by the company for laboratories and clinicians. Infectious diseases, including bacterial, viral, fungal, and parasitic species, are diagnosed through this technology. Operations focus on neuro-infectious pathogen detection within the biotechnology sector.
Who are the top competitors of Delve Bio?
Delve Bio's top competitors include Visby Medical, Inflammatix and Prenetics.
What products or services does Delve Bio offer?
Delve Bio offers Delve Detect.
Who are Delve Bio's investors?
Delve Bio has 3 investors. Key investors include Xontogeny, Google Ventures, and S32.